3 results match your criteria: "University Hospital Guy de Chauliac[Affiliation]"
J Neuroophthalmol
December 2018
Neurology Unit, Pierre Paul Riquet/Purpan University Hospital, Toulouse, France Ophthalmology Unit, Purpan University Hospital, Toulouse, France Radiology Unit, Purpan University Hospital, Toulouse, France Department of Medical Genetics, UF Molecular Genetics, Robert Debre University Hospital, Paris, France INSERM UMR-S1141,DHU PROTECT,Paris Diderot University,Robert Debre University Hospital,Paris, France Neurology Unit, University Hospital Guy de Chauliac, Montpellier, France.
Head Neck
May 2018
Otorhinolaryngology, Head and Neck Surgery Department, University Hospital Rangueil-Larrey, Toulouse, France.
Background: Given the particularities of olfactory neuroblastoma (ONB) and the lack of studies on the subject, a multicenter collaborative study was conducted to assess treatment strategy.
Methods: Fifty-three patients with ONB were included from the French Rare Head and Neck Cancer Expert Network (REFCOR) database: 16T1, 8T2, 19T3, and 10T4. All cases were treated endoscopically with skull base removal and repair in 26 cases (49%) and without external craniotomy.
J Neurosurg
July 2008
Department of Neurosurgery, University Hospital Guy de Chauliac, Montpellier, France.
Deep brain stimulation is now accepted as a safe and efficient treatment for movement disorders including selected types of dystonia and dyskinesia. Very little, however, is known about its effect on other movement disorders, particularly for "choreic" movements. Huntington disease is a fatal autosomal-dominant neurodegenerative disorder characterized by movement disorders, progressive cognitive impairment, and psychiatric symptoms.
View Article and Find Full Text PDF